Pfizer To Halt Funding in Allergy, Respiratory, Urology Areas

Pfizer Inc. plans to halt funding research in the areas of allergy, respiratory, urology, internal medicine and tissue repair, Chief Executive Officer Ian Read said on a conference call today.

To contact the reporter on this story: Tom Randall in New York at

To contact the editor responsible for this story: Bruce Rule at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.